Clinical trial
Generation of Clinical Grade Adenovirus Specific T Cells for Adoptive Immunotherapy After Allogeneic Stem Cell Transplantation : Clinical Trial
NCT02851576 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Generation of Clinical Grade Adenovirus Specific T Cells for Adoptive Immunotherapy After Allogeneic Stem Cell Transplantation : Clinical Trial
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2011
- Completion date
- March 31, 2015
- Enrollment
- 14 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adenovirus infection